ENTERO VUTM

 

 

EnteroVu ® 24% barium sulfate oral suspension is indicated for use in small bowel radiographic examinations to visualize the gastrointestinal (GI) tract. 

 

EnteroVu ®, barium sulfate oral suspension is licensed by Health Canada as Natural Health Products.

Indications and Usage:

 

EnteroVu ® 24% barium sulfate oral suspension is indicated for use in small bowel radiographic examinations to visualize the gastrointestinal (GI) tract.

 

 

IMPORTANT SAFETY INFORMATION:

 

For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents.

 

 

EnteroVu is manufactured by E-Z-EM Canada Inc. Montreal, Qc H1J 2Z4.

 

ENTERO VU is a trademark of E-Z-EM, Inc.

Contact us

Please fill out the form below and we will get back to you.

Different countries may have specific processes in place to handle reports of adverse reactions. To report an adverse reaction related to Bracco products, you can find specific contacts and information selecting the page "Pharmacovigilance" of your country.

* By checking this box and clicking the submit button of this page, I certify that I am a healthcare professional, and give permission for Bracco Imaging S.p.A., or parties acting on its behalf, to contact me with information regarding Bracco Imaging S.p.A., products and solutions, invitations to events and seminars, industry updates and other notifications. I understand that the information I provide will not be given to anyone outside Bracco Imaging S.p.A., except for the agents or representatives processing this request.